Clinical Trial Update: A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of STS101 for acute treatment of migraine, completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• STS101 (STS101)

Snippet

Sponsor: Satsuma Pharmaceuticals, Inc. | Conditions: Migraine, Migraine With Aura | Phase 3 | Status: COMPLETED | Results posted: 2023-07-03